NICOLE CLARK: Open Payments
NPI 1083110225 · LEBANON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$761 in 45 payments from 17 companies in 2025. Trend: 2023 $1,177 · 2024 $800 · 2025 $761
Food & beverage: $761
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $241 |
| Amgen Inc. | 11 | $140 |
| Medtronic, Inc. | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Lilly USA, LLC | 2 | $33 |
| Astellas Pharma US Inc | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Verona Pharma, Inc. | 1 | $20 |
Products named: UBRELVY, QULIPTA, OTEZLA, VRAYLAR, INTELLIS ADAPTIVESTIM, EVENITY, Kerendia, Ozempic.
Industry payments across IN — which companies pay providers there.
